热门资讯> 正文

Tango Therapeutics推出1亿美元的市场股票发行

2025-11-21 22:04

Tango Therapeutics(TNGX) 0

Tango Therapeutics (TNGX) entered a sales agreement with Leerink Partners to sell up to $100M of common stock through an at-the-market offering.
Leerink Partners will use commercially reasonable efforts to sell shares and will receive up to a 3% commission on gross proceeds.

More on Tango Therapeutics

Tango Therapeutics, Inc. (TNGX) Discusses Positive Clinical Data and Development Plans for Vopimetostat in MTAP-deleted Cancers Transcript
Tango Therapeutics, Inc. (TNGX) Discusses Positive Clinical Data and Development Plans for Vopimetostat in MTAP-deleted Cancers - Slideshow
Tango Therapeutics GAAP EPS of $0.14 beats by $0.15, revenue of $53.81M beats by $12.57M
Tango jumps on $225M funding and trial data for cancer drug
Seeking Alpha’s Quant Rating on Tango Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。